Dr. Marco Quarta, Ph.D. - Co-Founder and CEO - Rubedo Life Sciences; CEO, The Phaedon Institute
Dr. Marco Quarta, Ph.D. is Co-Founder and CEO of Rubedo Life Sciences ( https://www.rubedolife.com/ ), a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. The company's proprietary ALEMBICâ„¢ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders.
Dr. Quarta received his doctorate degree in Biotechnology from the University of Bologna and a Ph.D. in Neuroscience from the University of Padua. He completed a post-doc in Aging and Stem cell Biology in the lab of Prof. Thomas Rando at Stanford University and continued his work at Stanford directing a research team at the Center for Tissue Regeneration, Repair, and Restoration at the VA Hospital in Palo Alto, CA. While there, he established a translational program in regenerative medicine. He has over 35 publications and patents in the field of aging, stem cells, regenerative medicine, and rejuvenation.
Dr. Quarta also co-founded Wetware Concepts, Young European Biotech Network (YEBN), and Turn Biotechnology, and served as an executive board member of the European Federation of Biotechnologies. He currently sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) Calpoly Bridge program, and the advisory board at the Center for Healthcare Innovation. He is a member of the Paul F Glenn Center for the Biology of Aging Studies at Stanford University, one of the most prestigious institutions supporting the science of aging.
Dr. Quarta also serves as CEO and President for the Board of Directors of The Phaedon Institute ( https://www.phaedon.institute/ ), a think-tank organization that operates with the mission of supporting and enabling effective and sustainable growth in the field of aging and longevity sciences.
-
53:14
ProgressPotentialAndPossibilities
1 year agoDr. Leroy Hood, MD, Ph.D. - Co-Founder, Institute of Systems Biology (ISB); CEO, Phenome Health
14 -
44:17
ProgressPotentialAndPossibilities
1 year agoDr. John LaMattina, Ph.D. - Pharmaceutical Industry Thought Leader, Innovator And Mentor
17 -
46:16
American Optimist
2 years agoThe Year That Changed Medicine Forever | Francisco Gimenez Explains the Biotech Revolution.
61 -
1:25:23
Right2Freedom
1 year agoIn Conversation with Dr. Robert W Malone
255 -
1:25:23
HeartsofOak
1 year agoIn Conversation With . . . Robert W Malone MD
1.34K9 -
19:11
TrialSiteNews
1 year agoDr. Arturo Loaiza-Bonilla, co-founder and Chief Medical Officer of Massive Bio,
146 -
53:17
Four Corner Ministries News through a Christian Filter
1 year ago2022 APR 23 Dr Richard Urso Pt02 Big Pharma Makes Billions Rebranding Existing Drugs as New Products
484 -
19:05
Small Caps
8 months agoPharmAust's new CEO on his journey in biotech and vision for the company
45 -
43:32
In Vivo Podcast
25 days agoEp. 3 | In Vivo With Dr. Gregory Anderson on Medical Biotech
4 -
1:53:21
PeopleForPeople2022
7 months agoDR. RIMA E. LAIBOW (MD) TRUTH REPORTS WITH GUEST DR. ANA MARIA MIHALCIA (MD, PhD) 31ST OCTOBER 2023
1.19K4